skip to content

Circassia Pharmaceuticals Ord 0.08p

16:50 on 22/11/2017

Current Price 81.00p | Bid 81.00p | Ask 83.00p | Change -1.22%

Company Overview

Circassia Pharmaceuticals plc is a clinical-stage specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy products for the treatment of allergies. These product candidates were developed using the Company's innovative technology, ToleroMune®, which was initially developed at Imperial College, London, by Professors Mark Larché and Barry Kay, and was acquired by the Company, co-founded by Steven Harris and Charles Swingland, in 2006.

Stock Details

EPIC CIR
ISIN GB00BJVD3B28
Shares in Issue 284,889,171
Market cap £ 270.22m
Sector Pharmaceuticals & Biotechnology
Indices FTSE SmallCap
UK FTSE All Share

Financial Highlights Year Ended 31/12/2015

Turnover £10.80 million
Operating Profit £-66.40 million
Dividend Yield 0.00
Dividend Per Share 0.00
Dividend Cover 0.00
P/E Ratio -4.74
» More Financials

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 81.00p
Bid Price ? 81.00p
Ask Price ? 83.00p
Volume ? 23039
Change Today -1.00p
% Change Today -1.22%
Open 83.64p
Previous Close 81.00p
Intraday High 84.00p
Intraday Low 81.00p
52 Week High 356.00p
52 Week Low 81.05p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Aberdeen Ediston

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.